Understanding how patients accept long-acting HIV treatments in the US and Africa
Acceptability of Sustained-Release Antiretrovirals for Treatment in the US and sub-Saharan Africa
This study is looking at how comfortable people living with HIV feel about using long-acting injectable treatments, and it aims to understand what features of these treatments would make them more appealing, so that better options can be created for patients in the U.S. and sub-Saharan Africa.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10678651 on NIH RePORTER |
What this research studies
This research investigates the acceptability of long-acting injectable antiretroviral therapy (LAI ART) for treating HIV among patients in the United States and sub-Saharan Africa. It aims to identify the factors that influence patient preferences for these new treatment options through discrete choice experiments. By recruiting both ART naïve and experienced individuals, the study will gather insights on product attributes that enhance adherence and uptake of HIV treatment. The findings will help inform the development of more acceptable and effective treatment options for patients.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals living with HIV who are either new to antiretroviral therapy or currently receiving treatment.
Not a fit: Patients who are not living with HIV or those who are already fully adherent to existing treatment regimens may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved HIV treatment options that enhance patient adherence and viral load suppression.
How similar studies have performed: Previous research has shown promise in understanding patient preferences for HIV treatments, making this approach both relevant and potentially impactful.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Graham, Susan Marie — University of Washington
- Study coordinator: Graham, Susan Marie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.